Abstract

The FDA has approved a patent foramen ovale (PFO) occlusion device to help prevent recurrent stroke in patients with a PFO who've had an ischemic

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call